Recent Publications by Cancer Center of Boston: |
Same day Pegfilgrastim and CHOP chemotherapy for non-Hodgkin lymphoma.
OBJECTIVES: To determine if "same day" Pegfilgrastim (Pf) with CHOP... | 10th August, 2006
| The Cancer Center of Boston, Chestnut Hill, MA, USA.
| Am J Clin Oncol. 2006 Aug;29(4):361-3.
DOI Direct Link |
Same-day pegfilgrastim and chemotherapy.
Pegylated filgrastim is a new formulation of a neutrophil... | 7th January, 2006
| The Cancer Center of Boston in Boston, Plymouth, and Framingham,
| Cancer Invest. 2005;23(7):573-6.
DOI Direct Link |
Coagulopathy, following medical therapy, for carcinoma of the prostate.
Cancer of the prostate can be associated with coagulopathy characterized... | 8th October, 2005
| The Cancer Center of Boston, Boston, MA 02120, USA.
| Hematology. 2005 Feb;10(1):65-8.
DOI Direct Link |
Treatment of factor XI inhibitor using recombinant activated factor VIIa.
A 30-year-old female with severe factor XI deficiency of 0-2% acquired... | 26th May, 2005
| The Cancer Center of Boston, The New England Baptist Hospital, Harvard
| Haemophilia. 2005 Jan;11(1):20-5.
DOI Direct Link |
Tumor response and survival end points in clinical trials: a clinician's perspective.
Survival has become the gold standard for determining the relative... | 29th April, 2005
| The Cancer Center of Boston, Boston, Massachusetts 02120, USA.
| Am J Clin Oncol. 2004 Oct;27(5):494-6.
|
Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
Daily parenteral vitamin K supplement is now recommended by the U.S. Food... | 9th April, 2005
| Cancer Center of Boston, New England Baptist Hospital, Harvard Medical
| JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):388-98.
|
Capecitabine: fixed daily dose and continuous (noncyclic) dosing schedule.
BACKGROUND: Oral fluoropyrimidines are presumed to emulate a parenteral... | 30th December, 2004
| The Cancer Center of Boston, Boston, Massachusetts, USA.
| Cancer Invest. 2004;22(5):713-7.
|
Cutaneous hand and foot toxicity associated with cancer chemotherapy.
The purpose was to determine the optimal multifractionated (MF) dosing... | 20th February, 2004
| The Cancer Center of Boston in Boston, Massachusetts 02120, USA.
| Am J Clin Oncol. 2003 Oct;26(5):435-6.
DOI Direct Link |
Alternating doublets: establishing the optimal multifractionated dosing schedule to administer docetaxel, cisplatin, gemcitabine, and vinorelbine in combination.
The purpose was to determine the optimal multifractionated (MF) dosing... | 5th February, 2004
| Cancer Center of Boston, 125 Parker Hill Ave., Boston, Plymouth, MA
| Cancer Invest. 2003;21(6):830-6.
|
Very low dose warfarin as prophylaxis against ultrasound detected deep vein thrombosis following primary hip replacement.
One mg daily warfarin was compared to variable dose warfarin (PT 1.3-1.5... | 26th November, 2002
| The Cancer Center of Boston, Boston, Massachusetts, USA.
| Am J Hematol. 2002 Oct;71(2):69-74.
DOI Direct Link |
